Highlights: BCCL smashes 100x subscription! Should you bet on India’s 'Black Gold' monopoly or avoid the hype?

Explore which crypto presale could realistically turn $1K into $1M by 2026 by examining demand drivers, token structure, exit ...

It is in this context that SEBI’s December Board decision on Draft Red Herring Prospectuses (DRHPs) merits close examination.

The two IPOs, which follow radiopharma specialist Aktis Oncology's filing last week, have investors and industry watchers ...

Tesla's 10-billion-mile autonomy requirement builds an uncrossable data moat—use weakness below $400 to accumulate.

With India's gig workforce projected to grow to 2.35 Cr by 2030, how long will the race for quick deliveries take a toll on ...

Hedge fund crowdedness in 2025 diverged sharply by region, reflecting fundamentally different economic drivers across North America, EMEA, and APAC, according to Hazeltree, a leading provider of ...

Israel Englander, a highly successful hedge fund manager, sold Palantir and bought Tesla in the third quarter.

Merck is in talks to buy cancer drug developer Revolution Medicines in a deal that may be worth $28 billion to $32 billion ...

Led by dermatologist co-founders Reid Waldman and Tim Durso, Veradermics is developing an oral, non-hormonal treatment for men and women with pattern hair loss, a condition that affects 80 million ...

Women’s health exits topped $100 billion across 276 deals. New AOA Dx data show the category delivers healthcare M&A and ...

Sergey Brin, co-founder of Google, believes success comes from many failures. His journey with Google shows innovation ...